Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
J Cancer Res Clin Oncol. 2011 Mar;137(3):393-8. doi: 10.1007/s00432-010-0895-7. Epub 2010 Apr 29.
T lymphoma invasion and metastasis 1 (Tiam1) is a metastasis-related gene of T lymphoma that is also involved in the metastasis of a variety of other cancers, but little research has been done yet to test its usefulness as a prognostic marker in renal cell carcinoma (RCC). In the present study, we investigated Tiam1 expression and its prognostic significance in RCC. RCC surgical tissue samples were taken from 136 patients with RCC who had been followed up for 5 years. The Tiam1 expressions in the 136 clinical samples were tested by immunohistochemical assay to find their association with prognostic significance. We found that 93 of 136 (68.4%) paraffin-embedded archival RCC biopsies showed positive expression of Tiam1. Statistical analysis showed that there was significant difference of Tiam1 overexpression in patients categorized according to lymph node metastasis. Patients with higher Tiam1 expression had shorter overall survival time, whereas patients with lower Tiam1 expression had better survival. Multivariate analysis showed that Tiam1 overexpression was an independent prognostic indicator for patient's survival. Our results suggest that Tiam1 protein is a valuable marker of RCC progression. High Tiam1 expression is associated with poor overall survival in patients with RCC.
T 淋巴瘤侵袭转移蛋白 1(Tiam1)是 T 淋巴瘤的转移相关基因,也参与多种其他癌症的转移,但目前关于其作为肾细胞癌(RCC)预后标志物的研究甚少。本研究旨在探讨 Tiam1 在 RCC 中的表达及其预后意义。收集了 136 例随访 5 年的 RCC 手术组织标本,采用免疫组织化学方法检测 136 例临床样本中 Tiam1 的表达情况,并分析其与预后的关系。结果显示,93 例(68.4%)石蜡包埋的 RCC 活检组织中 Tiam1 呈阳性表达。统计学分析显示,Tiam1 过表达在根据淋巴结转移进行分类的患者中存在显著差异。Tiam1 高表达的患者总生存时间较短,而 Tiam1 低表达的患者生存时间较长。多因素分析显示,Tiam1 过表达是患者生存的独立预后指标。这些结果提示 Tiam1 蛋白是 RCC 进展的有价值标志物,Tiam1 高表达与 RCC 患者的总生存不良相关。